Aslan Fred bought ARTV
December 12, 2025 · Form 4 insider transaction
Aslan Fred bought 869,136 shares of Artiva Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
869,136
Price
$0.00
Total value
N/A
InsiderAslan Fred
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateDecember 12, 2025
Shares owned after1,213,135
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units award granted under the Issuer's 2024 Equity Incentive Plan ("RSUs").; On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I.